19-804608-T-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002819.5(PTBP1):āc.512T>Cā(p.Val171Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002819.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTBP1 | NM_002819.5 | c.512T>C | p.Val171Ala | missense_variant | 6/15 | ENST00000356948.11 | NP_002810.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PTBP1 | ENST00000356948.11 | c.512T>C | p.Val171Ala | missense_variant | 6/15 | 1 | NM_002819.5 | ENSP00000349428.4 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152184Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000485 AC: 12AN: 247208Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134496
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460020Hom.: 0 Cov.: 35 AF XY: 0.00000413 AC XY: 3AN XY: 726356
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152302Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | The c.512T>C (p.V171A) alteration is located in exon 6 (coding exon 6) of the PTBP1 gene. This alteration results from a T to C substitution at nucleotide position 512, causing the valine (V) at amino acid position 171 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at